Browse studies

Find your next paid study

27,384 recruiting studies available now

A Multi-part, Phase 1, First-Time-in-Human Study to Investigate Safety, Tolerability, and PK of VH4770359 in Healthy Participants

VH4770359 (also known as GSK4770359) is an antiretroviral compound. This first-in-human study aims to evaluate the safety, tolerability, and pharmacokinetics (…

HIV Infections

Estimated

~$500 – $11,250

Actual pay is set by the research site.

ViiV HealthcareNCT07525544

To Investigate the Outcomes of Rectus Abdominis Flap Detrusor Myoplasty for Urinary Retention

This investigates the outcomes of a surgical technique using the patient's own abdominal wall muscles to help contract the bladder in patients with urinary ret…

Urinary RetentionUrinary Retention After ProcedureUrinary Retention Postoperative

Estimated

~$10 – $750

Actual pay is set by the research site.

University Hospitals Cleveland Medical CenterNCT07379814

Phase 3

A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Remibrutinib in Patients With Secondary Progressive Multiple Sclerosis

The purpose of this study is to provide efficacy and safety data for remibrutinib in patients with secondary progressive multiple sclerosis (SPMS)

Secondary Progressive Multiple Sclerosis (SPMS)

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Novartis PharmaceuticalsNCT07225504

Phase 1

Educational Support Group Program for Carepartners of Bilingual and Spanish-speaking Persons With Progressive Forms of Aphasia and for Persons With Progressive Forms of Aphasia

The current study aims to examine the benefits of an education/support group program for individuals with progressive aphasia (caused by various etiologies, di…

Alzheimer DiseaseDementiaPrimary Progressive Aphasia+3 more

Estimated

~$500 – $7,500

Actual pay is set by the research site.

University of Texas at AustinNCT06511752

Phase 4

Identifying Ocrelizumab-resistant Lymphocytes in Lymphoid Tissue in Multiple Sclerosis

B cell-depleting therapies, such as ocrelizumab, are among the most effective medications currently available for the treatment of multiple sclerosis (MS). Thi…

Multiple Sclerosis, Relapsing-Remitting

Estimated

~$25 – $900

Actual pay is set by the research site.

University of California, San FranciscoNCT06495593

Phase 1

A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Subjects With Advanced Solid Tumors

The goal of this study is to assess the safety and tolerability of Mocertatug Rezetecan . The study will also see how the levels of Mo-Rez change over time at …

Solid TumorsNeoplasms

Estimated

~$150 – $4,500

Actual pay is set by the research site.

GlaxoSmithKlineNCT06431594

Observational

Pilot Study to Evaluate the Role of Endobronchial Ultrasound (EBUS) in the Diagnosis of Acute Pulmonary Embolism in Critically Ill Patients

Acute pulmonary embolism (PE) in critically ill patients is common and often life threatening. The diagnosis of acute PE is often entertained in intensive care…

Acute Pulmonary Embolism

Estimated

~$10 – $750

Actual pay is set by the research site.

University of California, Los AngelesNCT04047784

Phase 3

Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. This clinical trial will test if …

Coronary Artery Disease Risk Factors MultipleCoronary Artery Disease ProgressionPrevention & Control+1 more

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Duke UniversityNCT07232069

Observational

Ultra-low Dose, DaT-SPECT-guided Radiation Therapy for the Treatment of Parkinson's Disease

The purpose of this study is to investigate the use of ultra-low, anti-inflammatory doses of radiation therapy (RT) for the treatment of Parkinson's Disease (P…

Parkinson's Disease

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT07218952

Phase 2

A Phase 2, Multicentre, Randomised, Double-masked, Placebo-controlled, Parallel-group, Dose-range Finding Study, to Assess the Efficacy and Safety of Oral STL303 in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration

The purpose of this clinical research study is to look at how safe STL303 is and whether it works when given to people with Geographic Atrophy (GA) secondary t…

Geographic Atrophy

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Sitala Bio LTDNCT07606365

STXBP1 and SYNGAP1 Related Disorders (RD) Natural History Study

The purpose of this study is to find out more about STXBP1 and SYNGAP1 related disorders. The information gathered by this study will be used to prepare for cl…

Genetic DiseaseSTXBP1 Encephalopathy With EpilepsySYNGAP1-Related Intellectual Disability

Estimated

~$10 – $750

Actual pay is set by the research site.

Children's Hospital of PhiladelphiaNCT06555965

Observational

An Open-Label, Two-Arm Pilot Study of the Tolerability, Consumer Acceptability, and Exploratory Well-Being Outcomes of a Multi-Ingredient Protein Formula in Two Flavors in Healthy Adults

This is an open-label, two-arm pilot study designed to evaluate the tolerability, consumer acceptability, and well-being outcomes of a multi-ingredient protein…

Healthy

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Qualia Life SciencesNCT07827014